Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    "Alopecia universalis"
Show Display Options
Rank Status Study
1 Completed The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis
Conditions: Recalcitrant Alopecia Totalis;   Recalcitrant Alopecia Universalis
Interventions: Drug: Botulinum toxin A;   Drug: Normal saline injection
2 Completed Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
Conditions: Alopecia Totalis;   Alopecia Universalis;   Ophiasic Alopecia
Intervention: Drug: methylprednisolone sodium succinate
3 Recruiting Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention: Drug: Tofacitinib ointment
4 Active, not recruiting Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention: Drug: Tofacitinib administration
5 Completed Tofacitnib for the Treatment of Alopecia Areata and Variants
Conditions: Alopecia Areata (AA);   Alopecia Totalis (AT);   Alopecia Universalis (AU)
Intervention: Drug: Tofacitinib Administration
6 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
Intervention:
7 Recruiting A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Tralokinumab;   Drug: Placebo
8 Completed Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Targretin Gel 1%
9 Active, not recruiting A Study With INCB018424 Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
Condition: Alopecia Areata
Interventions: Drug: Placebo Cream;   Drug: INCB018424 Phosphate Cream

Study has passed its completion date and status has not been verified in more than two years.